✦ LIBER ✦

Tamoxifen (T) vs tamoxifen + uracil-ptegafur (T + UFT) in the adjuvant treatment of postmenopausal women with node positive breast cancer

✍ Scribed by L. Iglesias; A. Gómez; A. Moreno; A. Montaño; M. Ruiz; E. Calvo; P. Pastor; M. Noguer; J.L. Barea; J.A.Moreno Noguei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of HER2 and p53 expression on res

✍ F Akiyama; M Kurosumi; H Tsuda; M Toi; T Ikeda; G Sakamoto 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Pharmacoeconomic aspects of adjuvant ear

✍ P Piskur; M Sonc; T Cufer; S Borstnar; A Mrhar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Uracil-tegafur and tamoxifen vs cyclopho

✍ Park, Y; Okamura, K; Mitsuyama, S; Saito, T; Koh, J; Kyono, S; Higaki, K; Ogita, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

Postoperative adjuvant therapy with tamo

✍ T. Ikeda; J. Uchino; R. Abe; S. Miura; H. Koyama; K. Sugimachi; K. Akazawa; O. A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Anastrozole alone or in combination with

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 150 KB

277 POSTER Breast-conserving surgery (BC

✍ V. Semiglazov; E. Zhiltzova; V.V. Semiglazov; A. Kletsel; V. Ivanov; A. Bozhok; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB